 | • レポートコード：MRCLP3DB8195 • 出版社/出版日：LP Information / 2023年12月 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥541,680 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,083,360 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| LPインフォメーション社の最新調査レポート「無血清細胞凍結培地の世界市場」は、過去の販売実績から2022年の世界の無血清細胞凍結培地の総販売量を検討し、2023年から2029年の予測される無血清細胞凍結培地の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の無血清細胞凍結培地の市場規模を掲載し、XXX百万米ドル規模の世界の無血清細胞凍結培地市場の詳細な分析を提供します。本インサイトレポートは、世界の無血清細胞凍結培地業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。 また、本資料では、加速する世界の無血清細胞凍結培地市場における各社の独自のポジションをより深く理解するために、無血清細胞凍結培地製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。 世界の無血清細胞凍結培地市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。無血清細胞凍結培地の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。無血清細胞凍結培地の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。無血清細胞凍結培地の欧州市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。 無血清細胞凍結培地の世界主要メーカーとしては、BioLife Solutions、 Protide Pharmaceuticals、 Sigma-Aldrich、 Sartorius、 Akron Biotech、 Proteintech、 Thermo Fisher Scientific、 Meilune、 BestBio、 Shanghai XP Biomed、 Biological Industries、 Biosharp、 Beijing T&L Biotechnology、 Zhongshan Kangtian Yihe Biotechnology、 iCell Bioscience、 Sciprotech、 Nuwacell、 NCM Biotech、 Procell Life Science&Technology、 Shanghai Epizyme Biomedical Technology、 ExCell Bioなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。 本調査資料では、製品タイプ、用途、主要メーカー、主要地域、国別の無血清細胞凍結培地市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。 【市場細分化】 本調査では無血清細胞凍結培地市場をセグメンテーションし、種類別 (DMSOフリー細胞凍結培地、DMSO含有細胞凍結培地)、用途別 (大学＆研究機関、病院、バイオ企業)、および地域別 (アジア太平洋、南北アメリカ、欧州、および中東・アフリカ) の市場規模を予測しています。 ・種類別区分：DMSOフリー細胞凍結培地、DMSO含有細胞凍結培地 ・用途別区分：大学＆研究機関、病院、バイオ企業 ・地域別区分 南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） 【本レポートで扱う主な質問】 ・世界の無血清細胞凍結培地市場の10年間の市場状況・展望は？ ・世界および地域別に見た無血清細胞凍結培地市場成長の要因は何か？ ・無血清細胞凍結培地の市場機会はエンドマーケットの規模によってどのように変化するのか？ ・無血清細胞凍結培地のタイプ別、用途別の内訳は？ ・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？ ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：無血清細胞凍結培地の年間販売量2018-2029、地域別現状・将来分析 ・無血清細胞凍結培地の種類別セグメント：DMSOフリー細胞凍結培地、DMSO含有細胞凍結培地 ・無血清細胞凍結培地の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 ・無血清細胞凍結培地の用途別セグメント：大学＆研究機関、病院、バイオ企業 ・無血清細胞凍結培地の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 企業別世界の無血清細胞凍結培地市場 ・企業別のグローバル無血清細胞凍結培地市場データ：2018-2023年の年間販売量、市場シェア ・企業別の無血清細胞凍結培地の年間売上：2018-2023年の売上、市場シェア ・企業別の無血清細胞凍結培地販売価格 ・主要企業の無血清細胞凍結培地生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 無血清細胞凍結培地の地域別レビュー ・地域別の無血清細胞凍結培地市場規模2018-2023：年間販売量、売上 ・主要国別の無血清細胞凍結培地市場規模2018-2023：年間販売量、売上 ・南北アメリカの無血清細胞凍結培地販売の成長 ・アジア太平洋の無血清細胞凍結培地販売の成長 ・欧州の無血清細胞凍結培地販売の成長 ・中東・アフリカの無血清細胞凍結培地販売の成長 南北アメリカ市場 ・南北アメリカの国別の無血清細胞凍結培地販売量、売上（2018-2023） ・南北アメリカの無血清細胞凍結培地の種類別販売量 ・南北アメリカの無血清細胞凍結培地の用途別販売量 ・アメリカ市場 ・カナダ市場 ・メキシコ市場 ・ブラジル市場 アジア太平洋市場 ・アジア太平洋の国別の無血清細胞凍結培地販売量、売上（2018-2023） ・アジア太平洋の無血清細胞凍結培地の種類別販売量 ・アジア太平洋の無血清細胞凍結培地の用途別販売量 ・中国市場 ・日本市場 ・韓国市場 ・東南アジア市場 ・インド市場 ・オーストラリア市場 ・台湾市場 欧州市場 ・欧州の国別の無血清細胞凍結培地販売量、売上（2018-2023） ・欧州の無血清細胞凍結培地の種類別販売量 ・欧州の無血清細胞凍結培地の用途別販売量 ・ドイツ市場 ・フランス市場 ・イギリス市場 ・イタリア市場 ・ロシア市場 中東・アフリカ市場 ・中東・アフリカの国別の無血清細胞凍結培地販売量、売上（2018-2023） ・中東・アフリカの無血清細胞凍結培地の種類別販売量 ・中東・アフリカの無血清細胞凍結培地の用途別販売量 ・エジプト市場 ・南アフリカ市場 ・イスラエル市場 ・トルコ市場 ・GCC諸国市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・無血清細胞凍結培地の製造コスト構造分析 ・無血清細胞凍結培地の製造プロセス分析 ・無血清細胞凍結培地の産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・無血清細胞凍結培地の主要なグローバル販売業者 ・無血清細胞凍結培地の主要なグローバル顧客 地域別の無血清細胞凍結培地市場予測レビュー ・地域別の無血清細胞凍結培地市場規模予測（2024-2029） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・無血清細胞凍結培地の種類別市場規模予測 ・無血清細胞凍結培地の用途別市場規模予測 主要企業分析 BioLife Solutions、 Protide Pharmaceuticals、 Sigma-Aldrich、 Sartorius、 Akron Biotech、 Proteintech、 Thermo Fisher Scientific、 Meilune、 BestBio、 Shanghai XP Biomed、 Biological Industries、 Biosharp、 Beijing T&L Biotechnology、 Zhongshan Kangtian Yihe Biotechnology、 iCell Bioscience、 Sciprotech、 Nuwacell、 NCM Biotech、 Procell Life Science&Technology、 Shanghai Epizyme Biomedical Technology、 ExCell Bio ・企業情報 ・無血清細胞凍結培地製品 ・無血清細胞凍結培地販売量、売上、価格、粗利益（2018-2023） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
The global Serum Free Cell Freezing Medium market size is projected to grow from US$ 79 million in 2022 to US$ 99 million in 2029; it is expected to grow at a CAGR of 3.3% from 2023 to 2029.
United States market for Serum Free Cell Freezing Medium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Serum Free Cell Freezing Medium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Serum Free Cell Freezing Medium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Serum Free Cell Freezing Medium players cover BioLife Solutions, Protide Pharmaceuticals, Sigma-Aldrich, Sartorius, Akron Biotech, Proteintech, Thermo Fisher Scientific, Meilune and BestBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Serum Free Cell Freezing Medium Industry Forecast” looks at past sales and reviews total world Serum Free Cell Freezing Medium sales in 2022, providing a comprehensive analysis by region and market sector of projected Serum Free Cell Freezing Medium sales for 2023 through 2029. With Serum Free Cell Freezing Medium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Serum Free Cell Freezing Medium industry.
This Insight Report provides a comprehensive analysis of the global Serum Free Cell Freezing Medium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Serum Free Cell Freezing Medium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Serum Free Cell Freezing Medium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Serum Free Cell Freezing Medium and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Serum Free Cell Freezing Medium.
This report presents a comprehensive overview, market shares, and growth opportunities of Serum Free Cell Freezing Medium market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
DMSO Free Cell Freezing Medium
DMSO-containing Cell Freezing Medium
Segmentation by application
Universities & Research Institutes
Hospital
Biotech Company
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
BioLife Solutions
Protide Pharmaceuticals
Sigma-Aldrich
Sartorius
Akron Biotech
Proteintech
Thermo Fisher Scientific
Meilune
BestBio
Shanghai XP Biomed
Biological Industries
Biosharp
Beijing T&L Biotechnology
Zhongshan Kangtian Yihe Biotechnology
iCell Bioscience
Sciprotech
Nuwacell
NCM Biotech
Procell Life Science&Technology
Shanghai Epizyme Biomedical Technology
ExCell Bio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Serum Free Cell Freezing Medium market?
What factors are driving Serum Free Cell Freezing Medium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Serum Free Cell Freezing Medium market opportunities vary by end market size?
How does Serum Free Cell Freezing Medium break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Serum Free Cell Freezing Medium Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Serum Free Cell Freezing Medium by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Serum Free Cell Freezing Medium by Country/Region, 2018, 2022 & 2029
2.2 Serum Free Cell Freezing Medium Segment by Type
2.2.1 DMSO Free Cell Freezing Medium
2.2.2 DMSO-containing Cell Freezing Medium
2.3 Serum Free Cell Freezing Medium Sales by Type
2.3.1 Global Serum Free Cell Freezing Medium Sales Market Share by Type (2018-2023)
2.3.2 Global Serum Free Cell Freezing Medium Revenue and Market Share by Type (2018-2023)
2.3.3 Global Serum Free Cell Freezing Medium Sale Price by Type (2018-2023)
2.4 Serum Free Cell Freezing Medium Segment by Application
2.4.1 Universities & Research Institutes
2.4.2 Hospital
2.4.3 Biotech Company
2.5 Serum Free Cell Freezing Medium Sales by Application
2.5.1 Global Serum Free Cell Freezing Medium Sale Market Share by Application (2018-2023)
2.5.2 Global Serum Free Cell Freezing Medium Revenue and Market Share by Application (2018-2023)
2.5.3 Global Serum Free Cell Freezing Medium Sale Price by Application (2018-2023)
3 Global Serum Free Cell Freezing Medium by Company
3.1 Global Serum Free Cell Freezing Medium Breakdown Data by Company
3.1.1 Global Serum Free Cell Freezing Medium Annual Sales by Company (2018-2023)
3.1.2 Global Serum Free Cell Freezing Medium Sales Market Share by Company (2018-2023)
3.2 Global Serum Free Cell Freezing Medium Annual Revenue by Company (2018-2023)
3.2.1 Global Serum Free Cell Freezing Medium Revenue by Company (2018-2023)
3.2.2 Global Serum Free Cell Freezing Medium Revenue Market Share by Company (2018-2023)
3.3 Global Serum Free Cell Freezing Medium Sale Price by Company
3.4 Key Manufacturers Serum Free Cell Freezing Medium Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Serum Free Cell Freezing Medium Product Location Distribution
3.4.2 Players Serum Free Cell Freezing Medium Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Serum Free Cell Freezing Medium by Geographic Region
4.1 World Historic Serum Free Cell Freezing Medium Market Size by Geographic Region (2018-2023)
4.1.1 Global Serum Free Cell Freezing Medium Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Serum Free Cell Freezing Medium Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Serum Free Cell Freezing Medium Market Size by Country/Region (2018-2023)
4.2.1 Global Serum Free Cell Freezing Medium Annual Sales by Country/Region (2018-2023)
4.2.2 Global Serum Free Cell Freezing Medium Annual Revenue by Country/Region (2018-2023)
4.3 Americas Serum Free Cell Freezing Medium Sales Growth
4.4 APAC Serum Free Cell Freezing Medium Sales Growth
4.5 Europe Serum Free Cell Freezing Medium Sales Growth
4.6 Middle East & Africa Serum Free Cell Freezing Medium Sales Growth
5 Americas
5.1 Americas Serum Free Cell Freezing Medium Sales by Country
5.1.1 Americas Serum Free Cell Freezing Medium Sales by Country (2018-2023)
5.1.2 Americas Serum Free Cell Freezing Medium Revenue by Country (2018-2023)
5.2 Americas Serum Free Cell Freezing Medium Sales by Type
5.3 Americas Serum Free Cell Freezing Medium Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Serum Free Cell Freezing Medium Sales by Region
6.1.1 APAC Serum Free Cell Freezing Medium Sales by Region (2018-2023)
6.1.2 APAC Serum Free Cell Freezing Medium Revenue by Region (2018-2023)
6.2 APAC Serum Free Cell Freezing Medium Sales by Type
6.3 APAC Serum Free Cell Freezing Medium Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Serum Free Cell Freezing Medium by Country
7.1.1 Europe Serum Free Cell Freezing Medium Sales by Country (2018-2023)
7.1.2 Europe Serum Free Cell Freezing Medium Revenue by Country (2018-2023)
7.2 Europe Serum Free Cell Freezing Medium Sales by Type
7.3 Europe Serum Free Cell Freezing Medium Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Serum Free Cell Freezing Medium by Country
8.1.1 Middle East & Africa Serum Free Cell Freezing Medium Sales by Country (2018-2023)
8.1.2 Middle East & Africa Serum Free Cell Freezing Medium Revenue by Country (2018-2023)
8.2 Middle East & Africa Serum Free Cell Freezing Medium Sales by Type
8.3 Middle East & Africa Serum Free Cell Freezing Medium Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Serum Free Cell Freezing Medium
10.3 Manufacturing Process Analysis of Serum Free Cell Freezing Medium
10.4 Industry Chain Structure of Serum Free Cell Freezing Medium
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Serum Free Cell Freezing Medium Distributors
11.3 Serum Free Cell Freezing Medium Customer
12 World Forecast Review for Serum Free Cell Freezing Medium by Geographic Region
12.1 Global Serum Free Cell Freezing Medium Market Size Forecast by Region
12.1.1 Global Serum Free Cell Freezing Medium Forecast by Region (2024-2029)
12.1.2 Global Serum Free Cell Freezing Medium Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Serum Free Cell Freezing Medium Forecast by Type
12.7 Global Serum Free Cell Freezing Medium Forecast by Application
13 Key Players Analysis
13.1 BioLife Solutions
13.1.1 BioLife Solutions Company Information
13.1.2 BioLife Solutions Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.1.3 BioLife Solutions Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BioLife Solutions Main Business Overview
13.1.5 BioLife Solutions Latest Developments
13.2 Protide Pharmaceuticals
13.2.1 Protide Pharmaceuticals Company Information
13.2.2 Protide Pharmaceuticals Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.2.3 Protide Pharmaceuticals Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Protide Pharmaceuticals Main Business Overview
13.2.5 Protide Pharmaceuticals Latest Developments
13.3 Sigma-Aldrich
13.3.1 Sigma-Aldrich Company Information
13.3.2 Sigma-Aldrich Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.3.3 Sigma-Aldrich Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sigma-Aldrich Main Business Overview
13.3.5 Sigma-Aldrich Latest Developments
13.4 Sartorius
13.4.1 Sartorius Company Information
13.4.2 Sartorius Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.4.3 Sartorius Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sartorius Main Business Overview
13.4.5 Sartorius Latest Developments
13.5 Akron Biotech
13.5.1 Akron Biotech Company Information
13.5.2 Akron Biotech Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.5.3 Akron Biotech Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Akron Biotech Main Business Overview
13.5.5 Akron Biotech Latest Developments
13.6 Proteintech
13.6.1 Proteintech Company Information
13.6.2 Proteintech Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.6.3 Proteintech Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Proteintech Main Business Overview
13.6.5 Proteintech Latest Developments
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Information
13.7.2 Thermo Fisher Scientific Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.7.3 Thermo Fisher Scientific Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Thermo Fisher Scientific Main Business Overview
13.7.5 Thermo Fisher Scientific Latest Developments
13.8 Meilune
13.8.1 Meilune Company Information
13.8.2 Meilune Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.8.3 Meilune Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Meilune Main Business Overview
13.8.5 Meilune Latest Developments
13.9 BestBio
13.9.1 BestBio Company Information
13.9.2 BestBio Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.9.3 BestBio Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BestBio Main Business Overview
13.9.5 BestBio Latest Developments
13.10 Shanghai XP Biomed
13.10.1 Shanghai XP Biomed Company Information
13.10.2 Shanghai XP Biomed Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.10.3 Shanghai XP Biomed Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai XP Biomed Main Business Overview
13.10.5 Shanghai XP Biomed Latest Developments
13.11 Biological Industries
13.11.1 Biological Industries Company Information
13.11.2 Biological Industries Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.11.3 Biological Industries Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Biological Industries Main Business Overview
13.11.5 Biological Industries Latest Developments
13.12 Biosharp
13.12.1 Biosharp Company Information
13.12.2 Biosharp Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.12.3 Biosharp Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Biosharp Main Business Overview
13.12.5 Biosharp Latest Developments
13.13 Beijing T&L Biotechnology
13.13.1 Beijing T&L Biotechnology Company Information
13.13.2 Beijing T&L Biotechnology Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.13.3 Beijing T&L Biotechnology Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Beijing T&L Biotechnology Main Business Overview
13.13.5 Beijing T&L Biotechnology Latest Developments
13.14 Zhongshan Kangtian Yihe Biotechnology
13.14.1 Zhongshan Kangtian Yihe Biotechnology Company Information
13.14.2 Zhongshan Kangtian Yihe Biotechnology Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.14.3 Zhongshan Kangtian Yihe Biotechnology Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Zhongshan Kangtian Yihe Biotechnology Main Business Overview
13.14.5 Zhongshan Kangtian Yihe Biotechnology Latest Developments
13.15 iCell Bioscience
13.15.1 iCell Bioscience Company Information
13.15.2 iCell Bioscience Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.15.3 iCell Bioscience Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 iCell Bioscience Main Business Overview
13.15.5 iCell Bioscience Latest Developments
13.16 Sciprotech
13.16.1 Sciprotech Company Information
13.16.2 Sciprotech Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.16.3 Sciprotech Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Sciprotech Main Business Overview
13.16.5 Sciprotech Latest Developments
13.17 Nuwacell
13.17.1 Nuwacell Company Information
13.17.2 Nuwacell Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.17.3 Nuwacell Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Nuwacell Main Business Overview
13.17.5 Nuwacell Latest Developments
13.18 NCM Biotech
13.18.1 NCM Biotech Company Information
13.18.2 NCM Biotech Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.18.3 NCM Biotech Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 NCM Biotech Main Business Overview
13.18.5 NCM Biotech Latest Developments
13.19 Procell Life Science&Technology
13.19.1 Procell Life Science&Technology Company Information
13.19.2 Procell Life Science&Technology Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.19.3 Procell Life Science&Technology Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Procell Life Science&Technology Main Business Overview
13.19.5 Procell Life Science&Technology Latest Developments
13.20 Shanghai Epizyme Biomedical Technology
13.20.1 Shanghai Epizyme Biomedical Technology Company Information
13.20.2 Shanghai Epizyme Biomedical Technology Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.20.3 Shanghai Epizyme Biomedical Technology Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Shanghai Epizyme Biomedical Technology Main Business Overview
13.20.5 Shanghai Epizyme Biomedical Technology Latest Developments
13.21 ExCell Bio
13.21.1 ExCell Bio Company Information
13.21.2 ExCell Bio Serum Free Cell Freezing Medium Product Portfolios and Specifications
13.21.3 ExCell Bio Serum Free Cell Freezing Medium Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 ExCell Bio Main Business Overview
13.21.5 ExCell Bio Latest Developments
14 Research Findings and Conclusion